La Jolla Pharmaceutical is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of infectious diseases.
Business Model:
Revenue: $55.7M
Employees: 51-200
La Jolla Pharmaceutical was acquired by
Innoviva.
The acquisition happend on 2022-07-11.
Details of the transaction were not public
Address: 201 Jones Road
City: Waltham
State: MA
Zip: 02451
Country: US
La Jolla Pharmaceutical is a California-based biotechnology company that develops and commercializes novel therapeutics for the treatment of infectious diseases.
Contact Phone:
+18006513861
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
1/29/2014
Ticker Symbol:
LJPC
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2013 | Venture Round | $17.8M | 4/2011 | Venture Round | $5.2M | 9/2015 | Post-IPO Equity | $111.4M | 7/2014 | Post-IPO Equity | $56.6M |
---|
Announced Date | Name | Price |
---|---|---|
7/2020 | Tetraphase Pharmaceuticals |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|